RXST Q3 2024 Earnings — RxSight, Inc. Revenue & Financial Results | Market Cap Arena

RXSTRxSight, Inc.

$313M

Q3 2024 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$45M+48.1% YoY

Gross Profit

$25M55.5% margin

Operating Income

-$9M-20.3% margin

Net Income

-$6M-14.0% margin

EPS (Diluted)

$-0.16

QoQ Revenue Growth

+30.2%

Cash Flow

Operating Cash Flow

$730,000

Free Cash Flow

-$373,000

Stock-Based Comp.

$7M

Balance Sheet

Total Assets

$310M

Total Liabilities

$33M

Stockholders' Equity

$277M

Cash & Equivalents

$17M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$45M	$31M	+48.1%
Gross Profit	$25M	$14M	+83.7%
Operating Income	-$9M	-$13M	+26.3%
Net Income	-$6M	-$12M	+48.9%

Revenue Segments

L D D

$10M91%

Service Warranty Service Contracts And Accessories

$955,0009%